SynCardia Systems, a mechanical heart replacement technology company, agreed to go public via a SPAC merger with Altitude Acquisition, a publicly traded special purpose acquisition company, in a $480m deal. “We couldn’t be more excited to partner with Picard Medical in this transaction. SynCardia is a truly compelling opportunity to address a global health crisis and improve the lives of 64.3m patients suffering from heart failure around the globe. The problem is just too big to ignore. Throughout its history, SynCardia has proven itself the leader in TAH technology and we have every confidence in its ability to execute on its growth plans, expand its addressable market and deliver positive therapeutic outcomes to those who need it the most,” Gary Teplis, ALTU President and CEO.